Pulse Biosciences (PLSE) Retained Earnings (2015 - 2026)

Pulse Biosciences has reported Retained Earnings for 12 years, with the latest figure at -$506.5 million in Q2 2026.

• On a quarterly basis, Retained Earnings fell 18.77% year-over-year to -$506.5 million in Q2 2026; TTM through Jun 2026 was -$506.5 million, a 18.77% decrease from a year earlier, with the FY2025 full-year figure at -$463.3 million, down 18.64% from the prior year.
• Retained Earnings was -$506.5 million for Q2 2026 at Pulse Biosciences, down from -$463.3 million in the prior quarter.
• The five-year high for Retained Earnings was -$253.5 million in Q1 2022, with the low at -$506.5 million in Q2 2026.
• Average Retained Earnings over 5 years is -$358.7 million, with a median of -$347.1 million recorded in 2024.
• The largest YoY upside for Retained Earnings was 12.53% in 2022 against a maximum downside of 32.6% in 2022.
• Over 5 years, Retained Earnings stood at -$294.7 million in 2022, then retreated by 14.32% to -$336.9 million in 2023, then slipped by 15.9% to -$390.5 million in 2024, then declined by 18.64% to -$463.3 million in 2025, then retreated by 9.33% to -$506.5 million in 2026.
• The last three Retained Earnings figures came in at -$506.5 million (Q2 2026), -$463.3 million (Q4 2025), and -$445.8 million (Q3 2025), per Business Quant data.